<SEC-DOCUMENT>0001628280-21-008032.txt : 20210429
<SEC-HEADER>0001628280-21-008032.hdr.sgml : 20210429
<ACCEPTANCE-DATETIME>20210429073229
ACCESSION NUMBER:		0001628280-21-008032
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210429
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210429
DATE AS OF CHANGE:		20210429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAXTER INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000010456
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				360781620
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04448
		FILM NUMBER:		21867094

	BUSINESS ADDRESS:	
		STREET 1:		ONE BAXTER PKWY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		8479482000

	MAIL ADDRESS:	
		STREET 1:		ONE BAXTER PARKWAY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER TRAVENOL LABORATORIES INC
		DATE OF NAME CHANGE:	19880522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER LABORATORIES INC
		DATE OF NAME CHANGE:	19760608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bax-20210429.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:826dd12d-8468-4061-ac23-5990405c269d,g:bd0e9882-476d-431d-8f9c-76685af5d400,d:d04f624fd9064150ac68e5e824c7cda9--><html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:bax="http://www.baxter.com/20210429" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bax-20210429</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N18yLTEtMS0xLTA_01b0a969-a40f-4a9b-8b7f-f8aa9051bb0e">0000010456</ix:nonNumeric><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N18zLTEtMS0xLTA_c5d8a7a1-f35b-4715-819b-96f2ec79dead">false</ix:nonNumeric><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N180LTEtMS0xLTA_53c1862b-84d4-40ab-ac8f-1e15a2deab96">One Baxter Parkway</ix:nonNumeric><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N181LTEtMS0xLTA_80db2ecc-9402-46ae-ba30-045ea3fa7960">Deerfield</ix:nonNumeric><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N182LTEtMS0xLTA_4b0cf8dd-5c9b-40d0-ab38-4cd15ec0db64">Illinois</ix:nonNumeric><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N183LTEtMS0xLTA_13bb940a-45b0-41f8-9027-a248eba13a96">224</ix:nonNumeric><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N184LTEtMS0xLTA_9dbd8df3-4aea-4acb-9893-848c835dc364">948-2000</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bax-20210429.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i623fbd71edb740339f24b3d1bf6b6b27_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ce966737f4946bea6969e5f960595d4_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ee2cdee63054a728bdab3bbc2091ed1_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc37fe4f7eb44ce9a802bba7e41ecd80_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0d3aa90023d410ba9a13b2797ab19c9_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d9ebea52ec4f4a99c7121a0086ec7d_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4b953c090914f8083512d4702cb66f0_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if27539cfc956425b8aa74d4148540db6_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28511a856e34d93aea23e8bd48c29bf_D20210429-20210429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-29</xbrli:startDate><xbrli:endDate>2021-04-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id04f624fd9064150ac68e5e824c7cda9_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM184Mg_6c289126-7bcb-419f-b3f7-ce0a340552c4">8-K</ix:nonNumeric> </span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;13 OR 15(D) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM18yMjM_ade599fe-a48b-417d-b25a-01c753714263">April&#160;29, 2021</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl8wLTAtMS0xLTA_93c708af-863c-4181-8634-efa51b43db50">Baxter International Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl8zLTAtMS0xLTA_fa7258a5-29ad-4084-8586-797a8eb46f7b">Delaware</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl82LTAtMS0xLTA_4b480686-00cd-427e-98e1-f205f166f8fe">1-4448</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl82LTEtMS0xLTA_efc99145-45aa-4ce9-a181-50ddd0936533">36-0781620</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl85LTAtMS0xLTAvdGV4dHJlZ2lvbjplMWYxNGE5MWMxYTI0NmYyOTI4MjY2MWJkMTIyNjEwMV80_53c1862b-84d4-40ab-ac8f-1e15a2deab96">One Baxter Parkway</ix:nonNumeric>, <ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl85LTAtMS0xLTAvdGV4dHJlZ2lvbjplMWYxNGE5MWMxYTI0NmYyOTI4MjY2MWJkMTIyNjEwMV84_80db2ecc-9402-46ae-ba30-045ea3fa7960">Deerfield</ix:nonNumeric>, <ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl85LTAtMS0xLTAvdGV4dHJlZ2lvbjplMWYxNGE5MWMxYTI0NmYyOTI4MjY2MWJkMTIyNjEwMV8xMg_4b0cf8dd-5c9b-40d0-ab38-4cd15ec0db64">Illinois</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl85LTEtMS0xLTA_38bdc491-03c6-483e-a1c2-d43704cd3546">60015</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl8xMi0wLTEtMS0wL3RleHRyZWdpb246NDNkNmExYmMzY2ZhNDliY2JjOTk1N2FkNDhmNjEwMTlfNQ_13bb940a-45b0-41f8-9027-a248eba13a96">224</ix:nonNumeric>)<ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl8xMi0wLTEtMS0wL3RleHRyZWdpb246NDNkNmExYmMzY2ZhNDliY2JjOTk1N2FkNDhmNjEwMTlfOA_9dbd8df3-4aea-4acb-9893-848c835dc364">948-2000</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Former name or former address, if changed since last report)</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM180MDA_c20eec56-ebae-4d26-a97f-2ee17448afd3">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM180OTI_72d2661a-9d24-4fee-84cd-5fd74674a15e">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM181ODU_5ee01761-66f0-4ca4-a105-e7a3557330eb">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM182OTQ_1c5f74d1-b7c2-4651-90e4-2882367944ef">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i623fbd71edb740339f24b3d1bf6b6b27_D20210429-20210429" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8xLTAtMS0xLTA_5fe82c4d-9524-456b-a781-a11672ec3816">Common Stock, $1.00 par value</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i623fbd71edb740339f24b3d1bf6b6b27_D20210429-20210429" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8xLTItMS0xLTA_15b0c2a2-30a6-4e30-a522-7e4fee05eff0">BAX (NYSE)</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9ce966737f4946bea6969e5f960595d4_D20210429-20210429" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8xLTQtMS0xLTA_6ef43688-9c10-44e7-8ae3-1803f418f8a7">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0ee2cdee63054a728bdab3bbc2091ed1_D20210429-20210429" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8yLTQtMS0xLTA_20c8cc41-3245-4372-aa70-e5863d5033a9">Chicago Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icc37fe4f7eb44ce9a802bba7e41ecd80_D20210429-20210429" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8zLTAtMS0xLTA_67c4e42f-3deb-465b-8842-c9d1bcc1a25c">1.3% Global Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icc37fe4f7eb44ce9a802bba7e41ecd80_D20210429-20210429" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8zLTItMS0xLTA_148cff95-3c90-49c8-b7ca-41fcb151d623">BAX 25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie0d3aa90023d410ba9a13b2797ab19c9_D20210429-20210429" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8zLTQtMS0xLTA_4239770f-7fde-48bd-8b69-5e7fe0a2c63f">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i74d9ebea52ec4f4a99c7121a0086ec7d_D20210429-20210429" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl80LTAtMS0xLTA_0dee0baa-e4a4-434e-b79f-10418b2b3997">1.3% Global Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i74d9ebea52ec4f4a99c7121a0086ec7d_D20210429-20210429" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl80LTItMS0xLTA_dacbae0a-a84d-4b26-a7c6-26824c14e146">BAX 29</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic4b953c090914f8083512d4702cb66f0_D20210429-20210429" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl80LTQtMS0xLTA_18d037d9-9808-47b0-8b7a-c612868a63f5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if27539cfc956425b8aa74d4148540db6_D20210429-20210429" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl81LTAtMS0xLTA_d301a55d-f023-4926-91ff-ae9be3be0be4">0.4% Global Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if27539cfc956425b8aa74d4148540db6_D20210429-20210429" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl81LTItMS0xLTA_9a6d8351-f961-4496-a9a3-816c00ecb034">BAX 24</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if28511a856e34d93aea23e8bd48c29bf_D20210429-20210429" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl81LTQtMS0xLTA_743c01ad-d7f0-4cd5-8f5d-757c8c82f571">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter):</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM18xMTA0_0d8470e5-8935-4f77-9343-3b8a8922ff87">&#9744;</ix:nonNumeric> Emerging growth company</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act: &#160;&#160;&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="id04f624fd9064150ac68e5e824c7cda9_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;2.02 Results of Operations and Financial Condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On April 29, 2021, Baxter International Inc. (the Company) issued an earnings press release for the period ended March 31, 2021. The press release, including attachments, is furnished as Exhibit 99.1 to this report.</span></div><div style="margin-top:12pt"><span><br/></span></div><div id="id04f624fd9064150ac68e5e824c7cda9_10"></div><div style="-sec-extract:summary;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Exhibits.</span></div><div style="margin-top:10pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:16.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit&#160;Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20210331xex991.htm">Press Release Dated April 29, 2021</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="id04f624fd9064150ac68e5e824c7cda9_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date: April&#160;29, 2021</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BAXTER INTERNATIONAL INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">/s/ James K. Saccaro</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">James K. Saccaro</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>bax-20210331xex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa011.jpg" src="g782573page6aa011.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div><div style="margin-top:10pt;text-align:right"><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="margin-top:10pt;text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">FOR IMMEDIATE RELEASE</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Media Contact</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Steve Brett, (224) 948-5353</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:115%">media&#64;baxter.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Investor Contact</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Clare Trachtman, (224) 948-3020</font></div><div><font><br></font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:12pt;font-weight:400;line-height:120%">BAXTER REPORTS FIRST-QUARTER 2021 RESULTS</font></div><div style="margin-top:10pt;text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">First-quarter revenue of $2.9 billion increased 5% on a reported basis and 1% on both a constant currency and operational basis</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">First-quarter U.S. GAAP earnings per share (EPS) of $0.58 declined 9%&#59; Adjusted EPS of $0.76 declined 7%</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Baxter expects full-year 2021 sales growth of 8% to 9% on a reported basis, 5% to 6% on a constant currency basis and 4% to 5% on an operational basis</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Baxter expects full-year U.S. GAAP EPS of $2.85 to $2.93 and adjusted EPS of $3.47 to $3.55</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">DEERFIELD, Ill., APRIL. 29, 2021</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> &#8211; Baxter International Inc. (NYSE&#58;BAX), a leading global medical products company, today reported results for the first quarter of 2021. </font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8220;Baxter&#8217;s medically essential products are fundamental to healthcare, and many have proven pivotal in the fight against COVID-19,&#8220; said Jos&#233; (Joe) E. Almeida, chairman, president and chief executive officer. &#8220;Our life-sustaining portfolio, broad geographic reach and the ongoing momentum of our business transformation are all keys to our resilience. We are well positioned to strengthen our impact in the year ahead, fueled by our innovative product pipeline, relentless focus on execution, and capital deployment opportunities to benefit patients, customers and investors.&#8221; </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">First-Quarter Financial Results</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Worldwide sales in the first quarter totaled approximately $2.9 billion, an increase of 5% on a reported basis and 1% on both a constant currency and operational basis. Operational sales in the first quarter exclude the impact of foreign exchange and the company&#8217;s recent acquisition of </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">______________________</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See tables to the press release for reconciliations of non-GAAP measures used in this press release to the corresponding U.S. GAAP measures.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa011.jpg" src="g782573page6aa011.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div><div style="margin-top:10pt;text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-indent:36pt"><font><br></font></div><div style="margin-top:6pt;text-indent:36pt"><font><br></font></div><div style="margin-top:6pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">the rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Caelyx</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> and </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Doxil</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, the branded versions of liposomal doxorubicin, for specified territories outside of the United States (OUS).  </font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Sales in the U.S. totaled $1.2 billion, decreasing 3% on both a reported and operational basis. International sales of $1.8 billion increased 11% on a reported basis, 5% on a constant currency basis and 4% on an operational basis. </font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Starting this quarter, Baxter is adding the sales of its BioPharma Solutions contract manufacturing unit to its financial schedules, which break out sales by key product category. </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">Historical schedules</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> reflecting this new structure are available on Baxter&#8217;s Investor Relations website.  </font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> Performance in the first quarter was driven by Acute Therapies which delivered significant growth at both reported and constant rates, reflecting sustained higher levels of product demand due to the ongoing COVID-19 pandemic. BioPharma Solutions also delivered double-digit growth at reported and constant rates, driven by multiple collaborations to help manufacture COVID-19 vaccines on a contract basis. Additionally, Clinical Nutrition, Pharmaceuticals and Renal Care grew mid- to high single digits at reported rates, and low single digits at constant rates. This helped offset declines in Medication Delivery and Advanced Surgery, reflecting lower rates of hospital admissions and elective surgeries, respectively, in the wake of the ongoing pandemic, as well as a challenging comparison to performance in the previous year&#8217;s quarter.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Please see the attached schedules accompanying this press release for additional details on sales performance in the quarter, including breakouts by Baxter&#8217;s key product categories and geographic segments.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">For the first quarter, net income attributable to Baxter was $298 million, or $0.58 per diluted share, a decline of 9% on a U.S. GAAP (Generally Accepted Accounting Principles) basis. These results include special items totaling $88 million after-tax, which were primarily related to intangible asset amortization, business optimization charges, and a proposed settlement of shareholder litigation related to the company's investigation of foreign exchange gains and losses associated with certain intra-company transactions. On an adjusted basis, net income attributable to Baxter totaled $386 million, or $0.76 per diluted share, a 7% decline for the quarter. This exceeded the company&#8217;s previously issued guidance range of $0.63 to $0.65, driven by operational strength and a lower tax rate.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa011.jpg" src="g782573page6aa011.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div><div style="margin-top:10pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Business Highlights</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:7.15pt;font-weight:400;line-height:174%;position:relative;top:-3.85pt;vertical-align:baseline">2</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Baxter continues to achieve notable strategic milestones in pursuit of its Mission to Save and Sustain Lives. Among recent highlights, the company&#58; </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:14.15pt">Received U.S. FDA 510(k) clearance for its </font><font style="color:#0e32e1;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">AK 98</font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline"> (Artificial Kidney 98</font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">)</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> dialysis machine, designed to be a portable and easy-to-use system to administer hemodialysis treatments. Among its features, </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">AK 98</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> offers encrypted, two-way connectivity, which enables the system to pull prescriptions directly from the electronic medical record (EMR) for simplified workflow and data handling.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:14.15pt">Resubmitted to the U.S. FDA for 510(k) clearance of Baxter&#8217;s leading-edge </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Novum IQ</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> Infusion platform. The platform includes both large volume and syringe infusion pumps, and features Baxter's </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Dose IQ</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> Safety Software and </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">IQ Enterprise</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> Connectivity Suite, intuitive digital health technologies developed to protect patients, manage devices and provide advanced insights.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:14.15pt">Announced an </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">agreement with Moderna, Inc.,</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> for Baxter BioPharma Solutions to provide fill&#47;finish sterile manufacturing services and supply packaging for approximately 60 to 90 million doses of the Moderna COVID-19 vaccine in 2021. This partnership follows earlier agreements announced with BioNTech and Novavax to provide manufacturing services for their respective COVID-19 vaccines. </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:14.15pt">Strengthened its European and global pharmaceuticals portfolio through strategic rights acquisitions in line with the company&#8217;s strategy to bolster its pharmaceuticals business and expand its presence globally in specialty pharmaceuticals&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:11.4pt">The company acquired rights to specified territories outside of the U.S. to the widely prescribed chemotherapy medication </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Caelyx</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, known as </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Doxil</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> in several geographies, including the U.S.&#59; this supplements Baxter&#8217;s U.S. rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Doxil</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, acquired in 2019.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:11.4pt">Baxter also acquired full U.S. and specified OUS rights to the anti-nausea medication </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Transderm Scop</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, representing a key adjacency to Baxter&#8217;s industry-leading inhaled </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">__________________________</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:6.5pt;font-weight:400;line-height:174%;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:174%">See links to original press releases for additional product information.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa011.jpg" src="g782573page6aa011.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div><div style="margin-top:10pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">anesthetics portfolio&#59; Baxter previously had a license to sell the product to select customers in the U.S.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Corporate Responsibility</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Baxter is fully committed to promoting the power of diversity in support of its Mission. The company&#8217;s multidimensional </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">ACT (Activating Change Today) initiative</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> is focused on advancing racial justice for our employees, external stakeholders, and the markets and communities Baxter serves. Among recent highlights, Baxter&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:11.4pt">Announced </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">a new partnership with the American Diabetes Association (ADA)</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> through the ADA&#8217;s Health Equity Now platform to address health disparities for people with diabetes in Chicago&#8217;s underserved Black communities. The program is made possible through a three-year, $2 million grant from the Baxter International Foundation.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:11.4pt">Launched </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">a new Baxter-supported partnership with The Links, Incorporated</font><font style="color:#661de8;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> an international not-for-profit comprised of 16,000 women of color, to advance a multifaceted, community-based campaign to bring awareness and resources to help address the disproportionate challenges affecting Black Americans related to kidney health. Central to this effort is an educational toolkit developed by The National Kidney Foundation of Illinois focusing on the unique barriers facing the Black community.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Baxter continues to be recognized for its commitment to corporate social responsibility and workplace excellence. The company was most recently&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:13.8pt">Cited by </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:174%">Forbes</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> as one of America&#8217;s Best Employers for Diversity 2021.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:11.4pt">Recognized on Seramount&#8217;s inaugural Global Inclusion Index for the strength of local diversity, equality, and inclusion (DE&#38;I) efforts in Brazil, China, France, Germany, India, Ireland, Italy, Japan, Mexico, Singapore, and the United Kingdom. All Baxter geographies participating in the assessment earned recognition. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">2021 Financial Outlook</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">For full-year 2021&#58; Baxter now expects U.S. GAAP earnings of $2.85 to $2.93 per diluted share and adjusted earnings, before special items, of $3.47 </font></div><div style="margin-bottom:6pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa011.jpg" src="g782573page6aa011.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div><div style="margin-top:10pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">to $3.55 per diluted share. The company expects sales growth of 8% to 9% on a reported basis, 5% to 6% on a constant currency basis and 4% to 5% on an operational basis.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">For second-quarter 2021&#58; The company expects sales growth of 14% to 15% on a reported basis, 8% to 9% on a constant currency basis and 7% to 8% on an operational basis. The company expects U.S. GAAP earnings of $0.54 to $0.57 per diluted share and adjusted earnings, before special items, of $0.72 to $0.75 per diluted share.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Full-year and quarterly operational sales estimates for 2021 have been adjusted to exclude the impact of foreign exchange and the acquisition of specified OUS rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Caelyx&#47;Doxil</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">A webcast of Baxter&#8217;s first-quarter 2021 conference call for investors can be accessed live from a link on the company&#8217;s website at </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">www.baxter.com</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> beginning at 7&#58;30 a.m. CDT on April 29, 2021. Please see </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">www.baxter.com</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> for more information regarding this and future investor events and webcasts.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">About Baxter</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Every day, millions of patients and caregivers rely on Baxter&#8217;s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we&#8217;ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter&#8217;s employees worldwide are now building upon the company&#8217;s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.baxter.com</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and follow us on </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#0e32e1;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Facebook</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Non-GAAP Financial Measures </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release and the accompanying tables contain financial measures that are not calculated in accordance with U.S. GAAP. The non-GAAP financial measures include adjusted gross margin, adjusted selling, general and administrative expense, adjusted research and development expense, adjusted other operating income, net, adjusted operating income, adjusted operating margin, adjusted income before income taxes, adjusted income tax expense, adjusted net income, adjusted net income attributable to Baxter stockholders, and adjusted diluted earnings per share, all of which exclude special items, sales growth on a constant currency and operational basis, and free cash flow. Special items are excluded because they are highly variable or unusual, and of a size that may substantially affect the company&#8217;s reported operations for a period. Certain of those items represent estimates based on information reasonably available at the time of the press release. Future events or new information may result in different actual results.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net sales growth rates are presented on a constant currency basis. These measures provide information on the percentage change in net sales growth assuming that foreign currency exchange rates have not changed between the prior and current periods. Net sales growth rates are also </font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa011.jpg" src="g782573page6aa011.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div><div style="margin-top:10pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">presented on an operational basis. For the quarter ended March 31, 2021, operational sales growth excludes the impact of foreign exchange and the company&#8217;s recent acquisition of specified OUS rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Caelyx&#47;Doxil</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This measure provides information on the change in net sales growth rates assuming that foreign exchange rates remain constant and excluding the impact of the company&#8217;s recent acquisition of specified OUS rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Caelyx&#47;Doxil</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the quarter ended March 31, 2021, special items include intangible asset amortization, business optimization charges, acquisition and integration expenses, expenses related to European medical devices regulation and investigation and related costs. These items are excluded because they are highly variable or unusual and of a size that may substantially impact the company&#8217;s reported operations for a period. Additionally, intangible asset amortization is excluded as a special item to facilitate an evaluation of current and past operating performance and is consistent with how management and the company&#8217;s Board of Directors assess performance.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-GAAP financial measures may enhance an understanding of the company&#8217;s operations and may facilitate an analysis of those operations, particularly in evaluating performance from one period to another. Management believes that non-GAAP financial measures, when used in conjunction with the results presented in accordance with U.S. GAAP and the reconciliations to corresponding U.S. GAAP financial measures, may enhance an investor&#8217;s overall understanding of the company&#8217;s past financial performance and prospects for the future. Accordingly, management uses these non-GAAP measures internally in financial planning, to monitor business unit performance, and, in some cases, for purposes of determining incentive compensation. This information should be considered in addition to, and not as substitutes for, information prepared in accordance with U.S. GAAP.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Forward-Looking Statements </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">This release includes forward-looking statements concerning the company&#8217;s financial results and business development activities, including, but not limited to, its financial outlook for second quarter and full year 2021. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements&#58; demand for and market acceptance of risks for new and existing products&#59; product development risks&#59; product quality or patient safety concerns&#59; continuity, availability and pricing of acceptable raw materials and component supply&#59; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of a natural disaster, public health crises and epidemics&#47;pandemics, regulatory actions or otherwise)&#59; the impact of global economic conditions (including potential trade wars) and public health crises and epidemics, such as the ongoing coronavirus (COVID-19) pandemic, on us and our customers and suppliers, including foreign governments in countries in which we operate&#59; breaches or failures of the company&#8217;s information technology systems or products, including by cyberattack, unauthorized access or theft&#59; the adequacy of the company&#8217;s cash flows from operations (which may be negatively impacted by collectability concerns as a result of the ongoing COVID-19 pandemic or otherwise) and other sources of liquidity to meet its ongoing cash obligations and fund its investment program&#59; loss of key employees or inability to identify and recruit new employees&#59; future actions of regulatory bodies and other governmental authorities, including FDA, the Department of Justice, the SEC, the New York Attorney General and foreign regulatory agencies, including the continued delay in lifting the </font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa011.jpg" src="g782573page6aa011.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div><div style="margin-top:10pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">warning letter at our Ahmedabad facility or proceedings related to the investigation related to foreign exchange gains and losses&#59; the outcome of pending or future litigation, including the opioid litigation and litigation related to our internal investigation of foreign exchange gains and losses&#59; proposed regulatory changes of the U.S. Department of Health and Human Services in kidney health policy and reimbursement, which may substantially change the U.S. end stage renal disease market and demand for our peritoneal dialysis products, necessitating significant multiyear capital expenditures, which are difficult to estimate in advance&#59; failures with respect to compliance programs&#59; accurate identification of and execution on business development and R&#38;D opportunities and realization of anticipated benefits (including the acquisitions of </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cheetah Medical</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Seprafilm</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> Adhesion Barrier&#59; specified OUS rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Caelyx</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Doxil</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#59; and full U.S. and specified OUS rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Transderm Scop</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">)&#59; future actions of third parties, including payers&#59; U.S. healthcare reform and other global austerity measures&#59; pricing, reimbursement, taxation and rebate policies of government agencies and private payers&#59; the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies&#59; fluctuations in foreign exchange and interest rates&#59; the ability to enforce owned or in-licensed patents or the prevention or restriction of the manufacture, sale or use of products or technology affected by patents of third parties&#59; global, trade and tax policies&#59; any change in laws concerning the taxation of income (including current or future tax reform), including income earned outside the United States and potential taxes associated with the Base Erosion and Anti-Abuse Tax&#59; actions taken by tax authorities in connection with ongoing tax audits&#59; and other risks identified in Baxter&#8217;s most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter&#8217;s website. Baxter does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Baxter, AK 98, Caelyx, Cheetah Medical, Dose IQ, Doxil, IQ Enterprise, Novum IQ and Seprafilm are registered trademarks of Baxter International Inc. Transderm Scop is a registered trademark of Novartis AG.</font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">###</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_4"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 8</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share and percentage data)</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET SALES</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,946</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,802&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COST OF SALES</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,801</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,639&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GROSS MARGIN</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,145</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,163&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Net Sales</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">38.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">41.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(2.6&#160;pts)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SELLING, GENERAL AND ADMINISTRATIVE EXPENSES</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">627</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">628&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Net Sales</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">21.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">22.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(1.1&#160;pts)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RESEARCH AND DEVELOPMENT EXPENSES</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">128</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Net Sales</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">5.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(0.9&#160;pts)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OTHER OPERATING INCOME, NET</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NM</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING INCOME</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">390</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Net Sales</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">13.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">14.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(1.4&#160;pts)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INTEREST EXPENSE, NET</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OTHER EXPENSE, NET</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INCOME BEFORE INCOME TAXES</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">351</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INCOME TAX EXPENSE</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Income Before Income Taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">14.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2.6&#160;pts</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">300</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO BAXTER STOCKHOLDERS</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EARNINGS PER SHARE</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.59</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.65&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.58</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.64&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">WEIGHTED-AVERAGE NUMBER OF SHARES  OUTSTANDING</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">505</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">511</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">516&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADJUSTED OPERATING INCOME (excluding special items)&#185;</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">501</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADJUSTED INCOME BEFORE INCOME TAXES (excluding special items)&#185;</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">462</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADJUSTED NET INCOME ATTRIBUTABLE TO BAXTER STOCKHOLDERS (excluding special items)&#185;</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">386</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADJUSTED DILUTED EPS (excluding special items)&#185;</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.76</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.82&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to page 9 for a description of the adjustments and a reconciliation to U.S. GAAP measures.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - Not Meaningful </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 9</font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Adjustments and Reconciliation of U.S. GAAP to&#160;Non-GAAP&#160;Measures</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited, in millions)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company&#8217;s U.S. GAAP results for the three months ended March&#160;31, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">included special items which impacted the U.S. GAAP measures as follows&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Margin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, General and Administrative Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and Development Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Income, Net</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Before Income Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Tax Expense</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income Attributable to Baxter Stockholders</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Share</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,145</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">627</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">128</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">390</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">351</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">300</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">298</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.58</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported percent of net sales (or percent of income before income taxes for income tax expense)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European medical devices regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investigation and related costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,238</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">609</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">128</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">462</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">388</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.76</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted percent of net sales (or adjusted percent of income before income taxes for income tax expense)</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company&#8217;s U.S. GAAP results for the three months ended March&#160;31, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">included special items which impacted the U.S. GAAP measures as follows&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Margin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, General and Administrative Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and Development Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Income, Net</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Before Income Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Tax Expense</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income Attributable to Baxter Stockholders</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Share</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,163</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">628</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">409</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">378</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">333</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.64</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported percent of net sales (or percent of income before income taxes for income tax expense)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European medical devices regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investigation and related costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,241</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">590</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">528</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">497</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">426</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">425</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.82</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted percent of net sales (or adjusted percent of income before income taxes for income tax expense)</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2021 and 2020 included intangible asset amortization expense of $64 million ($52 million, or $0.10 per diluted share, on an&#160;after-tax&#160;basis) and $52 million ($41 million, or $0.08 per diluted share, on an&#160;after-tax&#160;basis), respectively.</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2021 and 2020 included charges of $27 million ($20 million, or $0.04 per diluted share, on an&#160;after-tax&#160;basis) and $32 million ($29 million, or $0.05 per diluted share, on an&#160;after-tax&#160;basis), respectively, associated with its programs to optimize its organization and cost structure on a global basis. Additionally, the company recorded a gain of $17 million ($17 million, or $0.03 per diluted share, on an after-tax basis) in 2020 for property it sold in conjunction with its business optimization initiatives.  </font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2021 included $1 million ($1 million, or $0.00 per diluted share, on an&#160;after-tax&#160;basis) of integration expenses related to the acquisition of the rights to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Caelyx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Doxil </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for specified territories outside of the U.S.  The company&#8217;s results in 2020 included $28 million ($22 million, or $0.04 per diluted share, on an after-tax basis) of acquisition and integration expenses.  This included acquisition and integration expenses related to the company's acquisitions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cheetah Medical</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seprafilm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the purchase of in-process R&#38;D assets, partially offset by the change in the estimated fair value of contingent consideration liabilities.</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2021 and 2020 included costs of $8 million ($6 million, or $0.01 per diluted share, on an&#160;after-tax&#160;basis) and $6 million ($4 million, or $0.01 per diluted share, on an after-tax basis) related to updating its quality systems and product labeling to comply with the new medical device reporting regulation and other requirements of the European Union&#8217;s regulations for medical devices that are scheduled to become effective in stages beginning in 2021.</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2021 and 2020 included costs of $11 million ($9 million, or $0.02 per diluted share, on an after-tax basis) and $18 million ($14 million, or $0.03 per diluted share, on an&#160;after-tax&#160;basis) for investigation and related costs. This included costs related to the company's investigation of foreign exchange gains and losses associated with certain intra-company transactions and related legal matters. The company also recorded a charge of $9 million in the first quarter of 2021 for a proposed settlement of shareholder litigation related to that investigation. Additionally, the company recorded incremental stock compensation expense in 2020 as it extended the terms of certain stock options that were scheduled to expire in the first quarter of 2020.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the company's use of non-GAAP financial measures, please see the Non-GAAP Financial Measures section of this press release.   </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_16"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 10</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales by Operating Segment</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">($ in millions)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Growth&#160;&#64;<br>Actual Rates</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Growth&#160;&#64;<br>Constant&#160;Rates</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,560&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,565&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Baxter</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,946</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,802</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the first quarter of 2021, the information provided to the company&#8217;s Chief Executive Officer for purposes of allocating resources and assessing performance was updated to reallocate contracted services activities performed at a German manufacturing facility from the company&#8217;s EMEA segment to its Americas segment. The contracted services performed at that facility are part of the company&#8217;s BioPharma Solutions business, which is managed as part of the Americas segment. Accordingly, the reported financial results of the Americas segment now include the contracted services activities performed at that facility. Segment results for the first quarter of 2020 have been recast to conform to the current year presentation. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Constant currency growth is a&#160;non-GAAP&#160;measure. For more information on the company&#8217;s use of&#160;non-GAAP&#160;financial measures, please see the Non-GAAP Financial Measures section of this press release.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_19"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 11</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales by Product Category</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">($ in millions)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Growth&#160;&#64;<br>Actual Rates</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Growth&#160;&#64;<br>Constant&#160;Rates</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Care&#160;&#185;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery&#160;&#178;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceuticals&#160;&#179;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Nutrition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#160;4</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#160;5</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acute Therapies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#160;6</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">7</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8312;</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Baxter</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,946</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,802</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:18pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:24.08pt">Includes sales of the company&#8217;s peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:24.08pt">Includes sales of the company&#8217;s intravenous (IV)&#160;therapies, infusion pumps, administration sets and drug reconstitution devices.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:24.08pt">Includes sales of the company&#8217;s premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:24.08pt">Includes sales of the company&#8217;s parenteral nutrition (PN) therapies and related products.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:24.08pt">Includes sales of the company&#8217;s biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:24.08pt">Includes sales of the company&#8217;s continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:24.08pt">Includes sales of contracted services the company provides to various pharmaceutical and biopharmaceutical companies.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:24pt">Includes sales of other miscellaneous product and service offerings.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning in the first quarter of 2021, the company's product category net sales disclosures separately present net sales from its BioPharma Solutions business, which was previously included within Other. Concurrent with that disaggregation of net sales from the company's BioPharma Solutions business, the company has also allocated certain previously unallocated sales deductions from Other to various categories, primarily based on their respective net sales.  Net sales for the first quarter of 2020 have been recast to conform to the current year presentation. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Constant currency growth is a&#160;non-GAAP&#160;measure. For more information on the company&#8217;s use of&#160;non-GAAP&#160;financial measures, please see the Non-GAAP Financial Measures section of this press release.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_22"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 12</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Product Category Sales by U.S. and International</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">($ in millions)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Growth</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Renal Care</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">922&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">666&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Delivery</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">411&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">449&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">678&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceuticals</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">552&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">516&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Nutrition</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advanced Surgery</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acute Therapies</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BioPharma Solutions</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Baxter</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,180</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,766</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,946</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,217</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,585</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,802</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_28"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 13</font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of&#160;Non-GAAP&#160;Financial Measure</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Cash Flow to Free Cash Flow</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:71.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operations - continuing operations</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">377</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">274</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(172)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Free cash flow - continuing operations</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">206</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">102</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Free cash flow is a&#160;non-GAAP&#160;measure. For more information on the company&#8217;s use of&#160;non-GAAP&#160;financial measures, please see the Non-GAAP Financial Measures section of this press release.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_31"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 14</font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of&#160;Non-GAAP&#160;Financial Measure</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Net Sales Growth As Reported to Operational Sales Growth</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">From The Three Months Ended March 31, 2020 to The Three Months Ended March 31, 2021</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales Growth<br>As&#160;Reported</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Caelyx and Doxil</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FX</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operational<br>Sales Growth*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Renal Care</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Delivery</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceuticals</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Nutrition</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advanced Surgery</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acute Therapies</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BioPharma Solutions</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Baxter</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Totals may not add across due to rounding</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operational sales growth is a&#160;non-GAAP&#160;measure. For more information on the company&#8217;s use of&#160;non-GAAP&#160;financial measures, please see the Non-GAAP Financial Measures section of this press release.</font></div><div style="margin-top:9pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib345f04b48e04e1ebc8200fc6c94c3f2_37"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 15</font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of&#160;Non-GAAP&#160;Financial Measure</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Projected Second Quarter and Full Year 2021 U.S. GAAP Sales Growth to Projected Operational Sales Growth, and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Projected Second Quarter and Full Year 2021 U.S. GAAP Earnings Per Share to Projected Adjusted Earnings Per Share</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales Growth Guidance</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2021*</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2021*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales Growth - U.S. GAAP</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14% - 15%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8% - 9%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OUS Caelyx and Doxil</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales Growth - Operational</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7% - 8%</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4% - 5%</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Totals may not foot due to rounding</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings Per Share Guidance</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2021*</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2021*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per Diluted Share - U.S. GAAP</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$0.54 - $0.57</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$2.85 - $2.93</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated intangible asset amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.11</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.42</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated business optimization charges</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.01</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.06</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated acquisition and integration expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.00</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.01</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated investigation and related costs</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.00</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.03</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated European medical devices regulation costs</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.02</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.06</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated income tax matter</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.04</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.04</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per Diluted Share - Adjusted</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$0.72 - $0.75</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3.47 - $3.55</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Totals may not foot due to rounding</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company&#8217;s outlook for U.S. GAAP earnings per share only includes the impact of special items that are known or expected as of the date of this release. Accordingly, actual U.S. GAAP earnings per share for the second quarter and full year of 2021 may differ significantly from those amounts. For example, the company&#8217;s outlook does not reflect the potential impact of future business or asset acquisitions or dispositions, intangible asset impairments, restructuring actions, developments related to gain or loss contingencies, debt extinguishment gains or losses, or unusual or infrequently occurring items that may occur during the remainder of 2021.</font></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bax-20210429.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:826dd12d-8468-4061-ac23-5990405c269d,g:bd0e9882-476d-431d-8f9c-76685af5d400-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bax="http://www.baxter.com/20210429" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.baxter.com/20210429">
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20210429_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20210429_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20210429_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20210429_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://www.baxter.com/role/DocumentandEntityInformationDocument">
        <link:definition>0001001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bax_GlobalNotes13Due2025Member" abstract="true" name="GlobalNotes13Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bax_GlobalNotes04Due2024Member" abstract="true" name="GlobalNotes04Due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bax_GlobalNotes13Due2029Member" abstract="true" name="GlobalNotes13Due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bax_CommonStock1.00PerValueMember" abstract="true" name="CommonStock1.00PerValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>bax-20210429_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:826dd12d-8468-4061-ac23-5990405c269d,g:bd0e9882-476d-431d-8f9c-76685af5d400-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="bax-20210429.xsd#DocumentandEntityInformationDocument"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>bax-20210429_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:826dd12d-8468-4061-ac23-5990405c269d,g:bd0e9882-476d-431d-8f9c-76685af5d400-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="bax-20210429.xsd#DocumentandEntityInformationDocument"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="extended" id="id699bea5b6dc4c998034a8c03efa669a_DocumentandEntityInformationDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_053eb19c-4fb8-4f58-b1d1-5df7abc1495a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_DocumentType_053eb19c-4fb8-4f58-b1d1-5df7abc1495a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a6ec4719-ce07-4bbc-9c6d-03a694ff8c28" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_DocumentPeriodEndDate_a6ec4719-ce07-4bbc-9c6d-03a694ff8c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_37e97156-5d2e-4b36-bf6f-f82a04aafa4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityRegistrantName_37e97156-5d2e-4b36-bf6f-f82a04aafa4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b76accf1-cb42-4bd5-9d4d-e5125089abb1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityCentralIndexKey_b76accf1-cb42-4bd5-9d4d-e5125089abb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b035bdca-662b-4ac1-8ba2-a7204217c99d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_AmendmentFlag_b035bdca-662b-4ac1-8ba2-a7204217c99d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_41f89203-cca9-444b-8662-376c312e448b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityIncorporationStateCountryCode_41f89203-cca9-444b-8662-376c312e448b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e5ea9d82-757a-4e70-a22c-a53baf8b4094" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityFileNumber_e5ea9d82-757a-4e70-a22c-a53baf8b4094" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7730c7af-d53c-475d-b180-d7be5b22bd6b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityTaxIdentificationNumber_7730c7af-d53c-475d-b180-d7be5b22bd6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_888b118b-ee1f-44e9-8872-2e99db7b2805" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityAddressAddressLine1_888b118b-ee1f-44e9-8872-2e99db7b2805" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c187f3fd-14e1-415d-963d-9a1c513d1c5c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityAddressCityOrTown_c187f3fd-14e1-415d-963d-9a1c513d1c5c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0e969fb3-862e-41cc-8e13-4b711bd8ddc0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityAddressStateOrProvince_0e969fb3-862e-41cc-8e13-4b711bd8ddc0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5cee1423-5f0f-4f18-a5be-52f0266b6095" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityAddressPostalZipCode_5cee1423-5f0f-4f18-a5be-52f0266b6095" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fbc57bef-2d89-4656-b09d-1dd6ea771304" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_CityAreaCode_fbc57bef-2d89-4656-b09d-1dd6ea771304" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cef61793-0a84-4f4f-9d90-a673f88fe99a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_LocalPhoneNumber_cef61793-0a84-4f4f-9d90-a673f88fe99a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_e952c2c1-50fa-437d-9235-f15e99787ca1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_WrittenCommunications_e952c2c1-50fa-437d-9235-f15e99787ca1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7111219a-e90e-4232-b35e-e884f6d1ac8d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_SolicitingMaterial_7111219a-e90e-4232-b35e-e884f6d1ac8d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6bc88079-971b-4fc7-a170-e6a1f5f6db68" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_PreCommencementTenderOffer_6bc88079-971b-4fc7-a170-e6a1f5f6db68" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_d1fc719b-62e7-43d7-b975-a9c27401c3fe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_d1fc719b-62e7-43d7-b975-a9c27401c3fe" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_67f5258a-d836-4b4b-b78c-ab2eec08f1c3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityEmergingGrowthCompany_67f5258a-d836-4b4b-b78c-ab2eec08f1c3" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ef0c9166-1d6d-4b00-8448-cd2303ee2aeb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_Security12bTitle_ef0c9166-1d6d-4b00-8448-cd2303ee2aeb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_809cb7f8-b8ab-49eb-9a24-d908c31f4805" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_TradingSymbol_809cb7f8-b8ab-49eb-9a24-d908c31f4805" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f7eac67a-b230-4c77-a48d-2c6b6a7522e2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_SecurityExchangeName_f7eac67a-b230-4c77-a48d-2c6b6a7522e2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_8c08e421-1181-48ee-a481-c3fad6ce16fd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:to="loc_dei_EntityListingsExchangeAxis_8c08e421-1181-48ee-a481-c3fad6ce16fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_8c08e421-1181-48ee-a481-c3fad6ce16fd_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_8c08e421-1181-48ee-a481-c3fad6ce16fd" xlink:to="loc_dei_ExchangeDomain_8c08e421-1181-48ee-a481-c3fad6ce16fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_21874973-439c-43db-8282-8850dd0ee400" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_8c08e421-1181-48ee-a481-c3fad6ce16fd" xlink:to="loc_dei_ExchangeDomain_21874973-439c-43db-8282-8850dd0ee400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_a3880b29-b81d-4414-8e61-675ac79d190e" xlink:href="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_21874973-439c-43db-8282-8850dd0ee400" xlink:to="loc_exch_XNYS_a3880b29-b81d-4414-8e61-675ac79d190e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_4caf2d56-2907-43ff-8cd6-5d76422ae9fe" xlink:href="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd#exch_XCHI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_21874973-439c-43db-8282-8850dd0ee400" xlink:to="loc_exch_XCHI_4caf2d56-2907-43ff-8cd6-5d76422ae9fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f1ed32ef-f331-41ed-abed-3eff0979ec45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f1ed32ef-f331-41ed-abed-3eff0979ec45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f1ed32ef-f331-41ed-abed-3eff0979ec45_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f1ed32ef-f331-41ed-abed-3eff0979ec45" xlink:to="loc_us-gaap_ClassOfStockDomain_f1ed32ef-f331-41ed-abed-3eff0979ec45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f1ed32ef-f331-41ed-abed-3eff0979ec45" xlink:to="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock1.00PerValueMember_537a083e-bdc1-4e4f-9ca6-f323dd07d0b9" xlink:href="bax-20210429.xsd#bax_CommonStock1.00PerValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:to="loc_bax_CommonStock1.00PerValueMember_537a083e-bdc1-4e4f-9ca6-f323dd07d0b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_12b951f6-64b5-456b-9303-b2e4e0084adb" xlink:href="bax-20210429.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:to="loc_bax_GlobalNotes13Due2025Member_12b951f6-64b5-456b-9303-b2e4e0084adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_99b49166-8692-4d49-871c-2f71700a484d" xlink:href="bax-20210429.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:to="loc_bax_GlobalNotes13Due2029Member_99b49166-8692-4d49-871c-2f71700a484d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_502fac63-890c-4eba-a3f6-5f5af4645f66" xlink:href="bax-20210429.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:to="loc_bax_GlobalNotes04Due2024Member_502fac63-890c-4eba-a3f6-5f5af4645f66" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bax-20210429_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:826dd12d-8468-4061-ac23-5990405c269d,g:bd0e9882-476d-431d-8f9c-76685af5d400-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_93e90d3f-ee8c-469f-aa9d-a1ac8329f412_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_95e184df-e5db-47b1-abed-091394e79bec_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_07521723-566b-4f2e-ad56-d1786dca0cc3_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_dd808865-d72c-49d3-9927-c97e3778fe6b_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_515aa36b-a2c7-41d4-b5b9-18c0a7fbe2d6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c882d181-de4e-4ef8-b53f-6f9f9c45136a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_93d19476-843a-4ac3-9b91-6f021b177115_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_22c23897-1570-4f18-972f-ffcbc9fb98f5_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_915ffbdf-33e6-4776-945d-bd6cb9e19798_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_986ed22f-eba5-4851-976e-bada24cfb810_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_5cc2a361-0ffd-4dc8-bd35-997ee32abd3e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e83fcc03-3265-46d9-a564-78035d84b95a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_26e00345-411c-4173-8cfc-6a0122ad47c3_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_09fed9e1-aa93-41ea-8a7e-bda318fd13fb_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_46697d8b-29c4-4a7a-9497-611ab06da522_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Global Notes due 2024</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_label_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 0.4% due 2024 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Global Notes due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member" xlink:href="bax-20210429.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes04Due2024Member" xlink:to="lab_bax_GlobalNotes04Due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c6aeba52-6e4f-46c1-a8c0-900690ac442d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_56e828bc-29bb-4ba4-85d4-8a69cf5269c1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XCHI_3a736a33-2bf2-4392-b5ad-7de6ddf42b5c_terseLabel_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHICAGO STOCK EXCHANGE, INC</link:label>
    <link:label id="lab_exch_XCHI_label_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHICAGO STOCK EXCHANGE, INC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI" xlink:href="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd#exch_XCHI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XCHI" xlink:to="lab_exch_XCHI" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_e2d1ef97-1aa8-4ebd-9466-457cdb0e6687_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2025</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2025 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member" xlink:href="bax-20210429.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2025Member" xlink:to="lab_bax_GlobalNotes13Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e55dce66-e36f-449b-96a4-9f502e6f6f26_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_bd7aa027-852e-4fa7-ab68-8411ee38a125_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_c922b06a-68ac-4766-b8c3-0787c8d806f0_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8625c428-b1c2-40a0-9ed3-765863ebb672_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_8ea6db4d-bac7-4f77-b382-1934b97b70ae_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ee06409f-b9c1-445d-8781-2c076f7fb485_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_1d3da507-f448-4f96-936f-4da0fc2b0581_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_d692db08-b7ac-477c-addf-2133607cc932_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_CommonStock1.00PerValueMember_e647cc84-6d34-4073-b42e-dbff85a3d291_terseLabel_en-US" xlink:label="lab_bax_CommonStock1.00PerValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 Per Value</link:label>
    <link:label id="lab_bax_CommonStock1.00PerValueMember_label_en-US" xlink:label="lab_bax_CommonStock1.00PerValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 Per Value [Member]</link:label>
    <link:label id="lab_bax_CommonStock1.00PerValueMember_documentation_en-US" xlink:label="lab_bax_CommonStock1.00PerValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 Per Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock1.00PerValueMember" xlink:href="bax-20210429.xsd#bax_CommonStock1.00PerValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_CommonStock1.00PerValueMember" xlink:to="lab_bax_CommonStock1.00PerValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_27634b42-c722-4556-9041-87058842cba8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_eadc1322-6607-4e2e-aa70-0ea5639a7d6c_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2029</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2029 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member" xlink:href="bax-20210429.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2029Member" xlink:to="lab_bax_GlobalNotes13Due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_01d5ebfd-558b-42ba-8392-39a9ea75761f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7d84b58d-c4ba-4370-a3f5-43f2c001f75b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_42b5fd88-eb23-48ad-b191-db761bd7966c_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_12274a39-058c-4312-a599-a5efbbabc831_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_ca0340a1-f79a-48eb-862d-bdcad9b820a6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bax-20210429_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:826dd12d-8468-4061-ac23-5990405c269d,g:bd0e9882-476d-431d-8f9c-76685af5d400-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="bax-20210429.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bdf33fac-b8a7-426a-add3-72fb15553bb4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdf33fac-b8a7-426a-add3-72fb15553bb4" xlink:to="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_8c08e421-1181-48ee-a481-c3fad6ce16fd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:to="loc_dei_EntityListingsExchangeAxis_8c08e421-1181-48ee-a481-c3fad6ce16fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_21874973-439c-43db-8282-8850dd0ee400" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_8c08e421-1181-48ee-a481-c3fad6ce16fd" xlink:to="loc_dei_ExchangeDomain_21874973-439c-43db-8282-8850dd0ee400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_a3880b29-b81d-4414-8e61-675ac79d190e" xlink:href="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_21874973-439c-43db-8282-8850dd0ee400" xlink:to="loc_exch_XNYS_a3880b29-b81d-4414-8e61-675ac79d190e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_4caf2d56-2907-43ff-8cd6-5d76422ae9fe" xlink:href="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd#exch_XCHI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_21874973-439c-43db-8282-8850dd0ee400" xlink:to="loc_exch_XCHI_4caf2d56-2907-43ff-8cd6-5d76422ae9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f1ed32ef-f331-41ed-abed-3eff0979ec45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f1ed32ef-f331-41ed-abed-3eff0979ec45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f1ed32ef-f331-41ed-abed-3eff0979ec45" xlink:to="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock1.00PerValueMember_537a083e-bdc1-4e4f-9ca6-f323dd07d0b9" xlink:href="bax-20210429.xsd#bax_CommonStock1.00PerValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:to="loc_bax_CommonStock1.00PerValueMember_537a083e-bdc1-4e4f-9ca6-f323dd07d0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_12b951f6-64b5-456b-9303-b2e4e0084adb" xlink:href="bax-20210429.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:to="loc_bax_GlobalNotes13Due2025Member_12b951f6-64b5-456b-9303-b2e4e0084adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_99b49166-8692-4d49-871c-2f71700a484d" xlink:href="bax-20210429.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:to="loc_bax_GlobalNotes13Due2029Member_99b49166-8692-4d49-871c-2f71700a484d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_502fac63-890c-4eba-a3f6-5f5af4645f66" xlink:href="bax-20210429.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4f4bc3e4-596e-45b4-8c0c-35bc288eeb41" xlink:to="loc_bax_GlobalNotes04Due2024Member_502fac63-890c-4eba-a3f6-5f5af4645f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_6acac77d-af9d-4b40-a5c3-6bd5de2ceb65" xlink:to="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_053eb19c-4fb8-4f58-b1d1-5df7abc1495a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_DocumentType_053eb19c-4fb8-4f58-b1d1-5df7abc1495a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a6ec4719-ce07-4bbc-9c6d-03a694ff8c28" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_DocumentPeriodEndDate_a6ec4719-ce07-4bbc-9c6d-03a694ff8c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_37e97156-5d2e-4b36-bf6f-f82a04aafa4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityRegistrantName_37e97156-5d2e-4b36-bf6f-f82a04aafa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b76accf1-cb42-4bd5-9d4d-e5125089abb1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityCentralIndexKey_b76accf1-cb42-4bd5-9d4d-e5125089abb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b035bdca-662b-4ac1-8ba2-a7204217c99d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_AmendmentFlag_b035bdca-662b-4ac1-8ba2-a7204217c99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_41f89203-cca9-444b-8662-376c312e448b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityIncorporationStateCountryCode_41f89203-cca9-444b-8662-376c312e448b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e5ea9d82-757a-4e70-a22c-a53baf8b4094" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityFileNumber_e5ea9d82-757a-4e70-a22c-a53baf8b4094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7730c7af-d53c-475d-b180-d7be5b22bd6b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityTaxIdentificationNumber_7730c7af-d53c-475d-b180-d7be5b22bd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_888b118b-ee1f-44e9-8872-2e99db7b2805" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityAddressAddressLine1_888b118b-ee1f-44e9-8872-2e99db7b2805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c187f3fd-14e1-415d-963d-9a1c513d1c5c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityAddressCityOrTown_c187f3fd-14e1-415d-963d-9a1c513d1c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0e969fb3-862e-41cc-8e13-4b711bd8ddc0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityAddressStateOrProvince_0e969fb3-862e-41cc-8e13-4b711bd8ddc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5cee1423-5f0f-4f18-a5be-52f0266b6095" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityAddressPostalZipCode_5cee1423-5f0f-4f18-a5be-52f0266b6095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fbc57bef-2d89-4656-b09d-1dd6ea771304" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_CityAreaCode_fbc57bef-2d89-4656-b09d-1dd6ea771304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cef61793-0a84-4f4f-9d90-a673f88fe99a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_LocalPhoneNumber_cef61793-0a84-4f4f-9d90-a673f88fe99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_e952c2c1-50fa-437d-9235-f15e99787ca1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_WrittenCommunications_e952c2c1-50fa-437d-9235-f15e99787ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7111219a-e90e-4232-b35e-e884f6d1ac8d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_SolicitingMaterial_7111219a-e90e-4232-b35e-e884f6d1ac8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6bc88079-971b-4fc7-a170-e6a1f5f6db68" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_PreCommencementTenderOffer_6bc88079-971b-4fc7-a170-e6a1f5f6db68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_d1fc719b-62e7-43d7-b975-a9c27401c3fe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_d1fc719b-62e7-43d7-b975-a9c27401c3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_67f5258a-d836-4b4b-b78c-ab2eec08f1c3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_EntityEmergingGrowthCompany_67f5258a-d836-4b4b-b78c-ab2eec08f1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ef0c9166-1d6d-4b00-8448-cd2303ee2aeb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_Security12bTitle_ef0c9166-1d6d-4b00-8448-cd2303ee2aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_809cb7f8-b8ab-49eb-9a24-d908c31f4805" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_TradingSymbol_809cb7f8-b8ab-49eb-9a24-d908c31f4805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f7eac67a-b230-4c77-a48d-2c6b6a7522e2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b00c43ed-87f5-4421-82d8-3c516e9f0227" xlink:to="loc_dei_SecurityExchangeName_f7eac67a-b230-4c77-a48d-2c6b6a7522e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g782573page6aa011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g782573page6aa011.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M&#Q%<7LCV!@M+7)\M#$';';)/?Z5VPP%)+WM6<4\=4;]W1&P==^* T+^VBL
ML?)\_<4BSLQG.WKTYK'V6$Y^3K\S;VF*Y.?I\C'TWXP^(K:\C>_\B[MLC>GE
MA&QWP1W^M;3P%)KW=&8PQU1/WM4;_P 0?B'K&B>(TL]'ND2#[.CNKQ*V&;)[
M^V*PPN$A4I\TT;XG%3ISM!F/IWQ&\=:I:S0V%J;R=6!,L5KN\M?3 &.?>M9X
M3#P=Y.WS,H8JO-6BK_(ZOP-K?C74_$;V^O1/;VD4!D*R6OEEB3@8./K^5<N)
MIX>%.]/?U.G#U*\IVJ;>AZ37G'H' ?%_5/L/@W[(K8DO9ECQ_LCYC_(#\:[\
M!#FJW['#CI\M*W<\*TVR?4M4M+&+[]Q*L0_$XKVYR4(N3Z'C0CS244>O^+_A
M[X5\/^$[_48H)A/%'B(F=C\Y( X^IKR</BZU6HHMGJU\+2ITW*QXS&\D4J/"
MS+(I!1E."#VQ7L-)JS/(6CT/0OB+XMUK^TX='6^DA6UMXQ<"%BGF2E06)(^O
M2N#"4*?+SVWV]#OQ5>?-R7V(?!'A35O&-M=W!UZYM(8'" [F?<V,G^(8P,?G
M3Q->%!I<MQ8>C.LF^:QS?BO3WTGQ'<Z:^H27YML(9I,@YP"1R3TS730GSTU*
MUKG-7CR3<;WL>A_!'3/GU356' "VZ'_QYO\ V6O/S&?PP^9WY?#>1U/Q2@TB
M?PA*NI7*03H=]H3RQD'8#J0>A_.N7!.:J^ZM.ITXQ0=/WGZ'SS7T!X)] ?"<
M:-)X42;3K98KQ3Y=VQ.7+COGT(Y Z5X&.]HJEI/3H>[@N3V=XK7J>?\ Q@U,
MWOC(6:GY+*%4Q_M-\Q_0C\J]# 0Y:5^YPXZ=ZENQL?!+3-]YJ>JLO$:+ A]S
MRW\E_.L<QG91@:Y?#5S.W^)>I_V9X$U J</< 6Z_\"//Z9KBP<.>LO+4[,7/
MDI,^=[&RGU&^@LK9-\\[B-%SC))Q7T$I*$7)]#P8Q<I**/5[K1/BC>:2^ES2
MVILWC\HHIC7Y>F,@9KRHU,'&7.M_F>HZ>*<>5[?(P;#X2>)/[1MOMEO EKYJ
M^:PG!(3//'TKHECJ7*^5ZF$<%4YE?8Y7Q1J7]K^*-2OE.4EG;R_]P<+^@%=-
M"')343FK3YZCD>U_"/3?L/@B.X9</>2M+^ ^4?\ H/ZUXV/GS5K=CU\%#EI7
M[G>5PG:% 'FGQ'\(>(O%FJ6OV%+<65K&0IDFP69NIQCV KTL)7I4(OFW9Y^*
MH5*TER[(X^V^%'C&SN([BVDMH9HSE)$N"&4^H.*ZWCJ$E9_D<BP5:+NBW??#
MWX@ZG"(;_4EN8@=P26\9AGUP141Q>&@[Q5OD7+"XB2M)_B2^'?A#J\6N6L^K
M/;)9P.)&6-][/@Y"]*57'P<&H;CI8&:FG/8T_'7POU'6=?EU72)H6^TX,L4S
M%2K 8R#CD<5GAL;&G#DGT-,3@Y3GSP*>B^#OB/H%JUIIE_:6T#OO9=ZL,\#/
M*GT%54Q&%J.\DV33H8FFK1=C+OOA-XMN=0N)Y)K6X>21F,K2X+DGKC'&:UCC
MJ*BDM#*6"K.3;/0/#FBZ]X5\#1Z?8V5M+JID=F,DV(P2>&SC)XQQ^M<%:I3K
M5N:3T.ZE3J4:7+%:F+IGPTU+6-9?5?&E\+EP?E@B<D$>A/&%]A6T\9"G#DH*
MQE#"2G+FK.Y1\8_"B]O=>:Z\/Q6T5I*@+1,VP(_0X '3H?SK3#XZ,86J;F=?
M!.4[T]BSX#\%^*_"6O">5;9K&<;+A%FR<=F QU!_F:G$XBC6A9;K8K#8>K1G
M=[">//ACJ>M^(9=6TJ:%A<!?,CE8J58 #(..1@"C#8R%.')/H&)P<JD^>/4J
MZ%X1^(_AJWEM]+NK*&&1M[(SJXW8QGE?:JJU\+5=YIDTZ&)I*T6;UWX/\2>)
MO"-S9>(=2B.I?:%EMRH'EH%7&#M ZY;]*PCB*5*JI4UI8VE0JU:;C4>IQ=C\
M+?&6F7\-[9O9QW$#[HW$V<$>Q%=DL;0G'EE>QR1P=:#NCJ_LOQ9_Z"&G_DG_
M ,37+S8+LSJY<7W1>L;'XAM:Z@=4O;660V[1VT49509&XW,0O11DX]:B4L-=
M<BZZEQCB+/F9Y]_PI_Q4!]VS_P"__P#]:N_Z_1\S@^HU3W'0[#^R]!L+':%-
MO D; '(R ,_K7BU)<\W+N>S3CR04>Q?K,L* "@ H * "@ H * "@ H * "@
5H * "@ H * "@ H * "@ H * /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>bax-20210429_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bax="http://www.baxter.com/20210429"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bax-20210429.xsd" xlink:type="simple"/>
    <context id="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="i623fbd71edb740339f24b3d1bf6b6b27_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="i9ce966737f4946bea6969e5f960595d4_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="i0ee2cdee63054a728bdab3bbc2091ed1_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="icc37fe4f7eb44ce9a802bba7e41ecd80_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="ie0d3aa90023d410ba9a13b2797ab19c9_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="i74d9ebea52ec4f4a99c7121a0086ec7d_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="ic4b953c090914f8083512d4702cb66f0_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="if27539cfc956425b8aa74d4148540db6_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <context id="if28511a856e34d93aea23e8bd48c29bf_D20210429-20210429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-29</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N18yLTEtMS0xLTA_01b0a969-a40f-4a9b-8b7f-f8aa9051bb0e">0000010456</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N18zLTEtMS0xLTA_c5d8a7a1-f35b-4715-819b-96f2ec79dead">false</dei:AmendmentFlag>
    <dei:EntityAddressAddressLine1
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N180LTEtMS0xLTA_53c1862b-84d4-40ab-ac8f-1e15a2deab96">One Baxter Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N181LTEtMS0xLTA_80db2ecc-9402-46ae-ba30-045ea3fa7960">Deerfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N182LTEtMS0xLTA_4b0cf8dd-5c9b-40d0-ab38-4cd15ec0db64">IL</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N183LTEtMS0xLTA_13bb940a-45b0-41f8-9027-a248eba13a96">224</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV80L2ZyYWc6MTUyNWMzZDM0N2MzNGUzN2IwY2JlMTQyMmYxNTFlYTUvdGFibGU6ZjExOTY3MzA0MDMyNDNkMWE1MTkyZTM0NGQ0YWVjNDcvdGFibGVyYW5nZTpmMTE5NjczMDQwMzI0M2QxYTUxOTJlMzQ0ZDRhZWM0N184LTEtMS0xLTA_9dbd8df3-4aea-4acb-9893-848c835dc364">948-2000</dei:LocalPhoneNumber>
    <dei:DocumentType
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM184Mg_6c289126-7bcb-419f-b3f7-ce0a340552c4">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM18yMjM_ade599fe-a48b-417d-b25a-01c753714263">2021-04-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl8wLTAtMS0xLTA_93c708af-863c-4181-8634-efa51b43db50">Baxter International Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl8zLTAtMS0xLTA_fa7258a5-29ad-4084-8586-797a8eb46f7b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl82LTAtMS0xLTA_4b480686-00cd-427e-98e1-f205f166f8fe">1-4448</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl82LTEtMS0xLTA_efc99145-45aa-4ce9-a181-50ddd0936533">36-0781620</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl85LTAtMS0xLTAvdGV4dHJlZ2lvbjplMWYxNGE5MWMxYTI0NmYyOTI4MjY2MWJkMTIyNjEwMV80_53c1862b-84d4-40ab-ac8f-1e15a2deab96">One Baxter Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl85LTAtMS0xLTAvdGV4dHJlZ2lvbjplMWYxNGE5MWMxYTI0NmYyOTI4MjY2MWJkMTIyNjEwMV84_80db2ecc-9402-46ae-ba30-045ea3fa7960">Deerfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl85LTAtMS0xLTAvdGV4dHJlZ2lvbjplMWYxNGE5MWMxYTI0NmYyOTI4MjY2MWJkMTIyNjEwMV8xMg_4b0cf8dd-5c9b-40d0-ab38-4cd15ec0db64">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl85LTEtMS0xLTA_38bdc491-03c6-483e-a1c2-d43704cd3546">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl8xMi0wLTEtMS0wL3RleHRyZWdpb246NDNkNmExYmMzY2ZhNDliY2JjOTk1N2FkNDhmNjEwMTlfNQ_13bb940a-45b0-41f8-9027-a248eba13a96">224</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6YWNkMjA1OTc3ZGNiNGJlMWE1NDBjZjhiMDliYzdmMGIvdGFibGVyYW5nZTphY2QyMDU5NzdkY2I0YmUxYTU0MGNmOGIwOWJjN2YwYl8xMi0wLTEtMS0wL3RleHRyZWdpb246NDNkNmExYmMzY2ZhNDliY2JjOTk1N2FkNDhmNjEwMTlfOA_9dbd8df3-4aea-4acb-9893-848c835dc364">948-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM180MDA_c20eec56-ebae-4d26-a97f-2ee17448afd3">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM180OTI_72d2661a-9d24-4fee-84cd-5fd74674a15e">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM181ODU_5ee01761-66f0-4ca4-a105-e7a3557330eb">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM182OTQ_1c5f74d1-b7c2-4651-90e4-2882367944ef">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i623fbd71edb740339f24b3d1bf6b6b27_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8xLTAtMS0xLTA_5fe82c4d-9524-456b-a781-a11672ec3816">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i623fbd71edb740339f24b3d1bf6b6b27_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8xLTItMS0xLTA_15b0c2a2-30a6-4e30-a522-7e4fee05eff0">BAX (NYSE)</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9ce966737f4946bea6969e5f960595d4_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8xLTQtMS0xLTA_6ef43688-9c10-44e7-8ae3-1803f418f8a7">NYSE</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="i0ee2cdee63054a728bdab3bbc2091ed1_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8yLTQtMS0xLTA_20c8cc41-3245-4372-aa70-e5863d5033a9">CHX</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="icc37fe4f7eb44ce9a802bba7e41ecd80_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8zLTAtMS0xLTA_67c4e42f-3deb-465b-8842-c9d1bcc1a25c">1.3% Global Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icc37fe4f7eb44ce9a802bba7e41ecd80_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8zLTItMS0xLTA_148cff95-3c90-49c8-b7ca-41fcb151d623">BAX 25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie0d3aa90023d410ba9a13b2797ab19c9_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl8zLTQtMS0xLTA_4239770f-7fde-48bd-8b69-5e7fe0a2c63f">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i74d9ebea52ec4f4a99c7121a0086ec7d_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl80LTAtMS0xLTA_0dee0baa-e4a4-434e-b79f-10418b2b3997">1.3% Global Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i74d9ebea52ec4f4a99c7121a0086ec7d_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl80LTItMS0xLTA_dacbae0a-a84d-4b26-a7c6-26824c14e146">BAX 29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic4b953c090914f8083512d4702cb66f0_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl80LTQtMS0xLTA_18d037d9-9808-47b0-8b7a-c612868a63f5">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if27539cfc956425b8aa74d4148540db6_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl81LTAtMS0xLTA_d301a55d-f023-4926-91ff-ae9be3be0be4">0.4% Global Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if27539cfc956425b8aa74d4148540db6_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl81LTItMS0xLTA_9a6d8351-f961-4496-a9a3-816c00ecb034">BAX 24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if28511a856e34d93aea23e8bd48c29bf_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGFibGU6NDE5MTA5NTVjMTMwNGMzMzlhYjcyYTI5MzA5NjJiZjIvdGFibGVyYW5nZTo0MTkxMDk1NWMxMzA0YzMzOWFiNzJhMjkzMDk2MmJmMl81LTQtMS0xLTA_743c01ad-d7f0-4cd5-8f5d-757c8c82f571">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="iaf422c59b4c640699afd13ad95326f81_D20210429-20210429"
      id="id3VybDovL2RvY3MudjEvZG9jOmQwNGY2MjRmZDkwNjQxNTBhYzY4ZTVlODI0YzdjZGE5L3NlYzpkMDRmNjI0ZmQ5MDY0MTUwYWM2OGU1ZTgyNGM3Y2RhOV8xL2ZyYWc6YzYxZDM2NzdhMzdhNDQ1NTkwMTBjMmFhYzBmNDlmYTMvdGV4dHJlZ2lvbjpjNjFkMzY3N2EzN2E0NDU1OTAxMGMyYWFjMGY0OWZhM18xMTA0_0d8470e5-8935-4f77-9343-3b8a8922ff87">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139787468374712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Apr. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 29,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Baxter International Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-0781620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Baxter Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">948-2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock1.00PerValueMember', window );">Common Stock, $1.00 Per Value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member', window );">1.3% Global Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member', window );">1.3% Global Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member', window );">0.4% Global Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.4% Global Notes due 2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | Common Stock, $1.00 Per Value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | 1.3% Global Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | 1.3% Global Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | 0.4% Global Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XCHI', window );">CHICAGO STOCK EXCHANGE, INC | Common Stock, $1.00 Per Value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CHX<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock1.00PerValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_CommonStock1.00PerValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XCHI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XCHI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ #3R=4F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    (  T\G5*'&'=B[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  T\G5*97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ #3R=4HH]@SB4!0  Q1T  !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  T\G5*?H!OPL0(
M .(,   -              "  =@-  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  #@5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>10</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>6</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bax-20210429.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bax-20210429.htm">bax-20210429.htm</File>
    <File>bax-20210331xex991.htm</File>
    <File>bax-20210429.xsd</File>
    <File>bax-20210429_cal.xml</File>
    <File>bax-20210429_def.xml</File>
    <File>bax-20210429_lab.xml</File>
    <File>bax-20210429_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/exch/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bax-20210429.htm": {
   "axisCustom": 0,
   "axisStandard": 2,
   "contextCount": 10,
   "dts": {
    "calculationLink": {
     "local": [
      "bax-20210429_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bax-20210429_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "bax-20210429.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bax-20210429_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bax-20210429_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bax-20210429.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 35,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 7,
    "total": 7
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 4,
   "memberStandard": 2,
   "nsprefix": "bax",
   "nsuri": "http://www.baxter.com/20210429",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20210429.htm",
      "contextRef": "iaf422c59b4c640699afd13ad95326f81_D20210429-20210429",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information Document",
     "role": "http://www.baxter.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20210429.htm",
      "contextRef": "iaf422c59b4c640699afd13ad95326f81_D20210429-20210429",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 6,
   "tag": {
    "bax_CommonStock1.00PerValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, $1.00 Per Value [Member]",
        "label": "Common Stock, $1.00 Per Value [Member]",
        "terseLabel": "Common Stock, $1.00 Per Value"
       }
      }
     },
     "localname": "CommonStock1.00PerValueMember",
     "nsuri": "http://www.baxter.com/20210429",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes04Due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.4% Global Notes due 2024 [Member]",
        "label": "Global Notes 0.4% due 2024 [Member]",
        "terseLabel": "0.4% Global Notes due 2024"
       }
      }
     },
     "localname": "GlobalNotes04Due2024Member",
     "nsuri": "http://www.baxter.com/20210429",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.3% Global Notes due 2025 [Member]",
        "label": "Global Notes 1.3% due 2025 [Member]",
        "terseLabel": "1.3% Global Notes due 2025"
       }
      }
     },
     "localname": "GlobalNotes13Due2025Member",
     "nsuri": "http://www.baxter.com/20210429",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.3% Global Notes due 2029 [Member]",
        "label": "Global Notes 1.3% due 2029 [Member]",
        "terseLabel": "1.3% Global Notes due 2029"
       }
      }
     },
     "localname": "GlobalNotes13Due2029Member",
     "nsuri": "http://www.baxter.com/20210429",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "exch_XCHI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHICAGO STOCK EXCHANGE, INC [Member]",
        "terseLabel": "CHICAGO STOCK EXCHANGE, INC"
       }
      }
     },
     "localname": "XCHI",
     "nsuri": "http://xbrl.sec.gov/exch/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC."
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001628280-21-008032-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-21-008032-xbrl.zip
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M';(#6?Y-O&G0)L,7B_*2OV1,(?8"=T H8-T:N3)ICV$=4B=,V4=3\Z1SU<E
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MS$''M?3<%/7Q?NC3AJ:W@6\!7>74K89-!&9;O8OJM!"G-EB'41?P!4W_7S8
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MAI'S\(ZMHYH<UQ#O]+#OK> '*?=\EAW.)J8G\XZ7!IU4HN"FZ%T:UIB&<V0
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MJH-!8V$]BG2/:R[;,W^"$XSP&:ALO,O^7K$,/^Q_4.&]><?^M*Y,:$G3TAI
M"EU^ID5.;!&JC]FD"U+H%$./=.RQ\^B'"^P);=')N6GS'?*77@0!G/&4+RA5
MP1M\$$2^$:T??JSPC][[QLO/FC6EUJHM_;BJJ$L_6[6L6E4:9XV-EEW]E?5J
MN]R;;2G ?%.M^I[3@J '("QO3.V_OZF]F8HBWD#VO$I43IC1>O&C9R\>U<;/
M^/!+_>7%S#=.\;N^P6>O7>"J2,C"LLRO\-S0 Q5R)HT[OJGS9UT#+*\\NBW4
MIX^&S(%'[H '<1E $'P7N<('YI"E@/OKIRT5R*K[(=5<'%^,C9H!P"NWJD?U
M'P,7IQ2<AGO4=<;Z_55HQ\;963KU3?>!W'>^=._G,?_:&9<2_3S=5TE*,,!2
MQX'!3_L[^XO$A\P<6JN<U9MK.L<W^_X75EU5A!K49O5B;Y#'3]?!P"KV_MHU
MG^>$&Q\BL_=F,0IW=V^R=VD6GUBKM*O:CBDW,V0;KZ&]OL9VW'_A@0XC!1?C
MM7$,;G0\56 Q$'[>3O?I\__E2?>YO+U_(+>?%NL_J6[#@C.G)_BCB7X5N)B:
M']&_F+#VQR;GOF\C-IEUPEB,&+72K)U)[&173JG50V(GQ\)H7:4KRV+J\]WM
M_3WYVKG[?'VSD93:WNPX(GDL$V%JO9$?$;8G&R#&P"9FP!:NS\(2VS*QJ#9K
M!<#X+O":/^R=:._6Q5I)3;>\2,NEZ;:+9<7//)^*^>0>^WMM8^?EC*FM":=:
M6SG;KTA-GR>]A9VX-Y:;"23]G":HN3EHMC&GBG([%A-C7576]1(6C"#3B)Y=
M6_';.1QS +X336D*LAK[WKNR19_ONU^^7-]\KI#/W9ON7><+Z=Q<D<[5U^N;
MZ_N'N\[#];^[I/O[M^[-_88.VJVTUJ,Y:)M:*W>V;1ZC6)DEB\6(:6IMB9L,
M&YK5W1N:F3MD$8.$1[,G,TGC:T)#4Y5: :S&3-[$0]J&A0VHK4D^FJ;4RT!"
MTIK;AS6G*FIYK;F[[GVW<W?Y&[?BKKK_[GZY_?:U>_-01A-.U=K2A,NLF7"\
M#)MZ4^(FN];-B2J#A=*$*Z[*NQ@:=6G!9003TH+; ?DTE'5+-'))0=* VX<!
M5U7.RFO W3[\UKTCM]^Z&'J[^8R-2FZ_=BODIOM0(M,M;#0CS;?,F@A',]].
MM$/%>/:(ENUX5N9LMINOI4I^7,W YUAWB9(=5Z<VGE7SP\[WG38F,P?WB>QZ
M=<,*NDSAN["VY&KQWD@OW=/:C 7S_N6LL.[P?L%\UC^M:2:KM;5]+/LNB,H$
M7#;SOLB"O.T)LJYL&%B3!%DF2W+]?([ZKMR!F8R;K92&O&MQ]S[.W]C<$;B5
M1G@T1V"MGCNCL3QM.([7 TR5J,FN"=<L4NSO (9<CL21B$YM+8NR'GE8?/C\
M-3O)7-PCST2QHW90I4/-<;V)LB"L5-$W$7,C'[N?;N^Z802./'1^WZZY9,X<
M-ZLMJD;^^DYF*BXCXW!ID5UKK5LLG45\E].(.VG).%SAS+>I/(QLN#*9;SF2
M>Z4S$HYFO]4W[#M?'M0<M>WGACT_RR:*<F;";9(2(B9>DH\XYYI%OSW@L.H2
M67;KA^1EPSS9P3$[@%=5)6NIF9F BRP9VZYA3**!8]EL.IP>N$6E00Y4PR5^
MS&J.Z@EV$UJ0=D-JSV-M7X:#Q-"NVGS(R%P!\Q6GTHAT'A[NKC]^?^A\_-(E
M#[?DYA;^?O-P=\O[#9,HL_$(4]^..N$Y/T)K-VE9,N22VMDE\9-M_%3W-?JM
M8-[(G!6H;2K0/G9^!Q%&[A]N+__YV^V7J^[=[B:XOWX]L@:HHTVB/JHT/\M?
MB\EL)%=L7'!7R"N5L>'NQS7=LU;6*HUZ:=2_JAU%>XB>K'.T;QY:J@$H#"?H
M62QE;$DNOYL(R,[7*$$,HMNYN[F^^7Q/OJ$^_%OG;GDLXL USX5=8T>^1,YN
M6TJKD6T"^T@]4]_&[$ZM[QTM/3&]LK?H>%E(L%M\KJK2V/-(T\SX/'=?*)Q7
M$M_6GLDJB2\^5U5I;IAFE14Z*[;C]N1L][4,F3ODSGVV<TKV,D,Z^\K#E6D%
M/C.V\">\ HHL<=[=.V=?.WP6^/)2U2/7[MF4-W"?90?I=K.%CS9'5VOW3MH\
M7*VE*L^Z(_HR2=\E]=.NH1!)-^T:GLB<^#J/>0#IKSV^1OR?[O7GWQZZ5Z>=
M?W?O.I^[Y.;[UX\X=N23\-[>$W+[_>'^H7-S=7WS6?IRI2]WW[[<_3L@CE=W
M7LU1X[#2^:6.ID$WJJV"X.;(@C8G;&^)%VK_AL81&V[(CAO9M3^/Q_C4HLQ?
MWE+?VXDMFFE3JDAKE, L[%S]X_L]F(4OQD^2$_:L6P&>@WACIIO4(J;/1MX[
MN,GMQE8W.6.9N#N*GV0QWW:9>5(6*;V7A-X<D_J.XAE9)/4EFH>V;C_*[-%;
MP0,3:TQ_*U9@HLA%X;%>L;P[\\XTC&T2X_*A86R4&W?,H]6;LN@]:SF@^= P
M,DSJ2[J)GAW4J9O3(O[CS8[?0U/K;)VP="VM8]UBO4)]Z=$H@IFWI#-<NYD?
M?2-[%F:.2;UT'HVZ=M#VY=*C(5,MI4<CJ75<77_YCO_M?I,NC$+8=<LJ25HY
MTBFR9U/FF-9+Y\.H*NWC#/#-EQ.C:,.Y,G?(!4K%>Y_V+ ;_-<S'#[_"/]&6
M1M0=F#8O-VC"XN%A3Y%KG*OM")NF;3#;/S_%O^SZ3$VE\=JIM.K/%V/',WW3
M 7 SB_KF([O /9_6^-OSP*<>PP7BSJ O_SV.3-(0/7>LSUSB.V1,!XR<D;[C
M$DH,YNFN.<8CXM 6?\@(-?X(/'\$D/<(M0UXR&6Z8^NF95+^'*SQ7;E7R.=.
MYQL9,>H%+O.4&/NK<7UPVN2'O_E*3LF-XY.OC-I :?W (DLW'+Y9UT2.ZDL2
M>#(-?QA2??)%<?O.J]-7:,]S,(WTQ2L""A]^[>$M2>XC^2\N;1I_?V/V:O5&
MOUKOU=NL6F<JZ^EMK5KMZTW]K*[7^MK_6F^B=X9QFAKB^;3G,OKCE/9]YIY3
MZXE.O-DMCP S<^==O-6=(4RMIL)8Z /\Y6U;4[4+\@VK7LX6@6HQI?%O27!+
M'<B9N;LFOA=G>:&-)L_".VC?=!ZN;V\Z7]#WN?S.9&7G5[/LH3/'&NYF&0,\
M,64,OB-8WHUCG^(?Q&]?0W:1^9.?!#8%V]!G1H68-H%OL."(WKL7&U]ZDW=_
M==+QN@?@X;HS FUJPF]/Z\)+H 5@'UB /F3_R.W]H<L8&<&J0X\P$+@&^4I=
M?2C055,K1*MJ^\DX2\D)R!&%IFFCAP!@,N,@($]#4Q\2$V"L X%P.+Z4B(0B
ME"W+>?)^>=MH7ZQ%.7,L+90L0GYRI6HJ<WCA)L##HF./G4<_7!BF-[;HY-RT
M^;'X2PO"7E-VKU0%RP\]0>'ZX<<*_VA.>16?:9I2;2[_N*JH2S];M6Q#::GM
MG:_:5MJ-YLY7;2GU^MD>5CT[RPM<&V"$[AZN#>6L5M_#JK6SVAZPU6CL ZZU
MLW2KON+%72//?H5?5XCDPUB=KXL'SJ\^NX[GH<P"/IFB\CE?A[MGH';8@PKY
MS&SF@OQ!K:MC@-9N>K[+K1'2?1XSVULQ5C.OA[]C'D-5A!_ZBCTRRQFC[EG<
M$]^")N&2VS%#U-J#<&IJ!9;WBW?6N5,6[H ;#,#-^5'A<-'=+-P1X0H6E5"G
M1R,=WW?-7B L#-\A'^DS[);<^X[^8^A88&D4CWC#0F_2I2ZZ!CWR#4\\I"[;
M+DJ>I=R\UYT>H<0=.^YVK1=W,<-C#]F8*0%PM D>QSNR6E'K^VEXDO+^96-Z
MR&S9N23XXA)\4VM)<I?D7A9R5[7]]-25Y"[)/8/D'@:,)<E+DB\+R=?.JI+<
M);F7AMP;QTI'D.1^;-R7D-PEM4MJ+P^UUZI2EY'D7AIRW]<\>DGNDMPS2.Y[
M&_"55WK/=>EUZC0N$50F8^9B^!_+!&P&VZ 6?,F)XR8_,$4>0D\DS82_^9@T
MPS/6IW\@3"2:O"BLVW\EX2'NSV)0UMK*V>&'$!SCI#^7":V:JM0D6@N'UKK$
M:@&Q6E6J$JN%PZI:4P[:1$&B]3!H5:7"5$2TUI5U^ZA)M.8 K57)A(N)5K7L
M:,W+%*-C]/L(2XA\:@],K#NAGL=\0D<.;/$OWEEB+S[#%!V JIMW )IK59+S
MWIDID;CIC/E=-R(K)G3#U$8)8@EB"6()8LF&)72+!UUU70M00G<-Z#8D="5T
M<PK=JJ*N&WG9(7P/G:EQ-$/\8^#!WSR/.&/?'(4&N.A[ES\S7-O"#,]@M^G4
M^039Z =>3.B>- _=S+LD@-W,,I0@EB#.$HBUC$R4E-"5T%T7NA*X^R3=@^:-
M2>A*Z.XTZ7%=K^<.X5N:('A'_S,PA9W+F]Z:ML\&KK# V5S3V_P8X;52QL)E
MG&O_EKAZZ%F=)0&LI%T)XOR#>%TOJ 2N!&XV@"N9@Z1?"5P)W&6VN(R#[Q_,
MW<!UQHS:9,0,W!@QV*.IP_HN&P163M/2ZZ6,A[>E:S!KNHH$L02Q!'&I0"RY
ML 1N/H%[T*+DL@&W*8$K@9M+X((A?L1$V]($Q:_M1^;YYH#&87%N\C(\MN?G
M,![>D/%PZ1G<3SQ<!L0E\4H02Q OZX8FH2NAFT_HRM+:/0)WW1Z)$K@2N-D
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MPJQ,;<FV>K-'1:C/_Y<K14C%5CVW_G#::'VG&WBU&QW__E_>MFNJ=K&%'K,
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M5ZD*UKMNHD&CIM1KVNYC][ A=;-D@E>6;=5WO]NVTCQK['ZSJM+4#I._D&H
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MI@)C1E DF>E@0*]I,5@G;8R)M;)C0(F?04[OUXU2D+/1B,>&FB@QSJ-C??@
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M_N'E4Y$$^G0T\1M'I+WG3_1=W#THV=G;C-JG'_O^X=$II%%_\''@Q^YD,2K
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M[^;X13PX_,_NY2R@A12A^ :]^CW;U5=02P,$%     @ #3R=4G/IU6K%"0
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MI]!M+G!TTY%Z>SL UAZ'_J:1QQN^<RE0_PCZ,A9B/;#?JMJ[ZEW=0<O$JW-
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M;9Q>'@SNE8T/^OB -[KI#7GY0+V9JZ&>W<>N>D,_/N)#/19ISF<#/!9/W6Q
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MMV>WG:G;FMUIXR=2P1\F/\U2P6>7::X7(?[A7J,0X5]TN;:""6&)H@(@)C'
M/.& 898  B$7(5$\1D[GF-J[&9MPPU/\MV )-RCQ!NI>%V>6L9MV]Y#:KN+#
M475D/5<(*BE;LQ1\6H)UK.O>0Y=:C4K+==<!:*OT]RT>LOWT.8=&-U:60=*V
M!<6Y_! C5@;!/6\>)!RZ.; .C(ZM>]:>EL>\WF7OL_3SU(*?2,*+-7L$B,8&
M8"+MZ(;*$+ P)"SD$F.D.I6?;G4TMC"Y75?Y>"QQ#;AC">HVOZX3F_ZL#3.S
MZ4!8]TK4!C8.58RZ;?[;U*,V.-E8DMK4WC\PO+:90A79XL<9OY[$1%-$A;3#
M)2$ %AP#&BO[@Q,F38SL3^@:"2J6QR;]1W!!@<Y=YU6Z]@N[,PE'5K*C_UZR
MK?6UATZK]@839JT;FTJL;^ G/?T@;R:_G__[8A+Q)"(\B@ 2!@$<,01$S!5(
ME"9*&8Q$['0@^M'BV*1F(9V__NE=\/'JW?G/P1L+\?7E3V^>!Q>7YVZZ>^*J
M76^=&#BRSEJ</^ H><?S%M45;9>R*UYMZ^[)TB!ZVP&^UMGN'WHM"\!H.9".
M5U,RC134IJ@CY9P"K(4"#!,"<)Q()4)-"$TZ+ ML=3,V)<+3J'[&%G>:YVZ3
MZK4LT(.J(9<%2LK6+/5;%MBFJ].R0 _:!EH6:'[(CK<LT,"*V[+ ]IN_Q;)
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M/Q>]X7O/<]&%I0'/16\ KYZ+WOQ#[WW8B\7B7F>;NX80H03SR/H?4VF3+$2
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M+FAT;5!+ 0(4 Q0    (  T\G5*-,K'W%!<  -6U   0              "
M 213  !B87@M,C R,3 T,CDN:'1M4$L! A0#%     @ #3R=4B,[S7J0 P
M#P\  !               ( !9FH  &)A>"TR,#(Q,#0R.2YX<V102P$"% ,4
M    "  -/)U2?0=L3HT!   > P  %               @ $D;@  8F%X+3(P
M,C$P-#(Y7V-A;"YX;6Q02P$"% ,4    "  -/)U2<^G5:L4)  #&20  %
M            @ 'C;P  8F%X+3(P,C$P-#(Y7V1E9BYX;6Q02P$"% ,4
M"  -/)U2(QD[E%D/  !1D0  %               @ ':>0  8F%X+3(P,C$P
M-#(Y7VQA8BYX;6Q02P$"% ,4    "  -/)U2Q0$U$DH)  "22P  %
M        @ %EB0  8F%X+3(P,C$P-#(Y7W!R92YX;6Q02P4&      < !P#(
) 0  X9(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
